Saltar al contenido
Merck

The molecular basis of leukocyte adhesion involving phosphatidic acid and phospholipase D.

The Journal of biological chemistry (2014-09-05)
Francis Speranza, Madhu Mahankali, Karen M Henkels, Julian Gomez-Cambronero
RESUMEN

Defining how leukocytes adhere to solid surfaces, such as capillary beds, and the subsequent migration through the extracellular matrix, is a central biological issue. We show here that phospholipase D (PLD) and its enzymatic reaction product, phosphatidic acid (PA), regulate cell adhesion of immune cells (macrophages and neutrophils) to collagen and have defined the underlying molecular mechanism in a spatio-temporal manner that coincides with PLD activity timing. A rapid (t½ = 4 min) and transient activation of the PLD1 isoform occurs upon adhesion, and a slower (t½ = 7.5 min) but prolonged (>30 min) activation occurs for PLD2. Importantly, PA directly binds to actin-related protein 3 (Arp3) at EC50 = 22 nm, whereas control phosphatidylcholine did not bind. PA-activated Arp3 hastens actin nucleation with a kinetics of t½ = 3 min at 300 nm (compared with controls of no PA, t½ = 5 min). Thus, PLD and PA are intrinsic components of cell adhesion, which reinforce each other in a positive feedback loop and react from cues from their respective solid substrates. In nascent adhesion, PLD1 is key, whereas a sustained adhesion in mature or established focal points is dependent upon PLD2, PA, and Arp3. A prolonged adhesion could effectively counteract the reversible intrinsic nature of this cellular process and constitute a key player in chronic inflammation.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
3,4-Dihidroxi-L-fenilalanina, ≥98% (TLC)
Sigma-Aldrich
1,2-Dioleoyl-sn-glycero-3-phosphocholine, lyophilized powder
Supelco
3,4-Dihidroxi-L-fenilalanina, Pharmaceutical Secondary Standard; Certified Reference Material
USP
3,4-Dihidroxi-L-fenilalanina, United States Pharmacopeia (USP) Reference Standard
3,4-Dihidroxi-L-fenilalanina, European Pharmacopoeia (EP) Reference Standard